MARKET

NAGE

NAGE

Niagen Bioscience, Inc
NASDAQ
3.270
+0.040
+1.24%
Opening 12:35 07/28 EDT
OPEN
3.240
PREV CLOSE
3.230
HIGH
3.315
LOW
3.220
VOLUME
204.26K
TURNOVER
--
52 WEEK HIGH
11.29
52 WEEK LOW
3.120
MARKET CAP
260.44M
P/E (TTM)
15.01
1D
5D
1M
3M
1Y
5Y
1D
Niagen Bioscience announces publication on muscle epigenetic age
TipRanks · 3h ago
Aging Cell Publishes Study In 'Aging Cell' Showing Niagen NR Supplementation Reduces Muscle Biological Aging and Supports Healthy Muscle Function
Benzinga · 4h ago
Niagen Bioscience reports analysis finds Niagen NR cuts muscle epigenetic age by about 2.5 years in 5-month trial
PUBT · 4h ago
Niagen Bioscience (NAGE) Gets a Buy from Roth MKM
TipRanks · 1d ago
Niagen Bioscience CEO to speak at Canaccord Genuity Growth Conference
PUBT · 1d ago
Weekly Report: what happened at NAGE last week (0720-0724)?
Weekly Report · 1d ago
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
Barchart · 1d ago
Niagen Bioscience schedules Q2 earnings call after market close
PUBT · 07/21 12:32
More
About NAGE
Niagen Bioscience, Inc. is a global bioscience company dedicated to promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offer the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment focuses on the pharmaceutical development of its nicotinamide adenine dinucleotide (NAD) precursor portfolio for potential therapeutic applications in rare diseases.

Webull offers Niagen Bioscience Inc stock information, including NASDAQ: NAGE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAGE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAGE stock methods without spending real money on the virtual paper trading platform.